reference/5462844

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5462844

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural
endingPage	1389
issn	2641-7650
issueIdentifier	12
pageRange	1380-1389
publicationName	Kidney360
startingPage	1380
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_47b82c0b9fd0c53483463fb1eb08a678 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6a06f795e2776f8b4caa4cc13fa47f47 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_503228b167d50529af13e7efff2904b7
bibliographicCitation	Charytan DM, Hsu JY, Mc Causland FR, Waikar SS, Ikizler TA, Raj DS, Landis JR, Mehrotra R, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM, Himmelfarb J, Anderson AH, Hung AM, Sharma S, Weiner DE, , . Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial. Kidney360. 2020 Dec;1(12):1380–9. doi: 10.34067/kid.0004342020.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50f0677789d2eae2f7f46a17ff1244cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b77427c4fbb6d5baa5477974958b0ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56a122cf5c039ba07bcb276eb11305ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58d7615f55e2775792db6561ef6c65e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_035a0c8e5c8b2990eaffdb394edd9878 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ebb73775895f4f559e5bae67b742946 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c9e680d8e8682fb13e6383a6d7da723 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c37e3876f9d32dbcc7886a68e431497c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a14ba1465cff37551fc4a6c508167e40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f372a65c9f88e3a73cab793adbea026 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee56e6e33377f494367e22e7a9fa8362 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cb6e6d3de97d9980439b7419b07bac4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb6cb76679add9af5ee6d2388c85c8b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e78932ec13587e13c915c69ee47e4fb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9738c892db4dd7ca06d32709d65cf470 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d22ecb76d8a27f7fd6a4f374f694cb18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba0581fa0221b91c51adfe1642f8b28c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1aa3fb5dd68bae2728d3b79cdaaa4ead http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_595209d8e3b3ce20a5d7305745c0cb25
date	2020-12-31^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8815530 https://doi.org/10.34067/kid.0004342020 https://pubmed.ncbi.nlm.nih.gov/35372900
isPartOf	https://portal.issn.org/resource/ISSN/2641-7650 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/49517
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial
discusses	http://id.nlm.nih.gov/mesh/M0011788 http://id.nlm.nih.gov/mesh/M0010676
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007676Q000628 http://id.nlm.nih.gov/mesh/D007548Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006830Q000009 http://id.nlm.nih.gov/mesh/D014057 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006435Q000009 http://id.nlm.nih.gov/mesh/D010865
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8135 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8236 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3637 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6883 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453

Showing number of triples: 1 to 59 of 59.